08182017Headline:

Montgomery County, Pennsylvania

HomePennsylvaniaMontgomery County

Michael Monheit

Zofran Lawsuit Update: Boston Court Considers Proposed Short Form Complaint

More than 260 families say GlaxoSmithKline’s anti-nausea drug Zofran can cause birth defects. In lawsuit after lawsuit, parents from across the country claim the pharmaceutical giant failed to warn them of Zofran’s alleged risks, despite the drug’s status as America’s […]

Michael Monheit

In Zofran Lawsuit Master Complaint, Novartis Named As Defendant Alongside GlaxoSmithKline

Over 250 families have filed suit against GlaxoSmithKline, claiming the company’s anti-nausea drug Zofran, a common off-label treatment for morning sickness, causes birth defects. While the litigation began as a disparate collection of lawsuits filed in numerous district courts, the […]

Michael Monheit

Key Court-Mandated Deadlines Announced For Zofran Lawsuits

Four new court orders have spurred a flurry of activity among more than 200 families who have filed Zofran lawsuits against GlaxoSmithKline. Four New Court Orders Set Essential Timeline For Zofran MDL Discovery As of June 7, 2015, 265 Zofran […]

Michael Monheit

Last Generic Zofran Lawsuits Filed In Alabama, As Generic Liability Ends

As of June 1, 2016, more than 250 Zofran lawsuits have been filed in the US District Court of Massachusetts. Most of the claims, however, didn’t start in the Boston court where they are now consolidated. In fact, 151 of them were […]

Michael Monheit

Massachusetts Judge Finalizes Upcoming Zofran Lawsuit Timeline

After a successful status conference on May 17, 2016, Judge F. Dennis Saylor, IV has issued a new court order in the Zofran MDL, a consolidated litigation that now includes over 200 birth defect lawsuits. Master Pleadings – MDL Order No. 14 […]

Michael Monheit

New Florida Zofran Lawsuit Transferred To Boston

On May 16, 2016, the Judicial Panel on Multi-District Litigation issued another Conditional Transfer Order, sending a recently-filed Zofran birth defect lawsuit to join more than 200 lawsuits already pending in Massachusetts. The cases, which have been “consolidated” for pre-trial proceedings, […]

Michael Monheit

New Timeline Proposed For Master Pleadings In Zofran Lawsuits

More than 200 families have filed suit against GlaxoSmithKline, the manufacturer of Zofran, a drug parents say causes major birth defects. Their lawsuits have been consolidated in the US District of Massachusetts, a federal court in Boston, since October of […]

Michael Monheit

As Zofran Lawsuits Mount, Government Settles For Less In Big Pharma Cases

Public Citizen, a key industry watchdog advocating public interests in Washington, has released its newest update to a major 2012 report, which analyzed the most significant court judgments and settlements between pharmaceutical corporations and the federal and state governments. In […]

Michael Monheit

With Discovery On Horizon, Zofran Lawsuits Await Court’s Fact Sheet Opinion

Two months of negotiation have been relatively fruitful, GlaxoSmithKline’s legal counsel writes in a new memorandum to the US District Court of Massachusetts. Filed on April 8, 2016, the memo presents the company’s position on the fact sheets, standardized fact-gathering […]

Michael Monheit

Here’s The Info Zofran Lawsuit Plaintiffs Want From GlaxoSmithKline

More than 230 Zofran lawsuits, alleging that GlaxoSmithKline’s anti-nausea drug causes major birth defects, have now been consolidated in the US District Court of Massachusetts. Parents from across the country, who have filed suit on behalf of their minor children, […]